USD 9.26
(0.24%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 | 3.93 Million USD | -100.0% |
2023 | 49.81 Million USD | 99.27% |
2022 | 25 Million USD | 25.0% |
2021 | 20 Million USD | -50.0% |
2020 | 40 Million USD | -67.85% |
2019 | 124.4 Million USD | 43.62% |
2018 | 86.62 Million USD | -5.15% |
2017 | 91.32 Million USD | -13.16% |
2016 | 105.16 Million USD | -18.42% |
2015 | 128.91 Million USD | -6.36% |
2014 | 137.66 Million USD | 1.97% |
2013 | 135 Million USD | -5.26% |
2012 | 142.5 Million USD | 2170.92% |
2011 | 6.27 Million USD | -4.2% |
2010 | 6.55 Million USD | -3.82% |
2009 | 6.81 Million USD | -3.75% |
2008 | 7.07 Million USD | -58.66% |
2007 | 17.11 Million USD | 521.23% |
2006 | 2.75 Million USD | -6.13% |
2005 | 2.93 Million USD | -5.32% |
2004 | 3.1 Million USD | -84.02% |
2003 | 19.4 Million USD | 27.95% |
2002 | 15.16 Million USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 2.94 Million USD | -100.0% |
2024 FY | 3.93 Million USD | -92.09% |
2024 Q3 | 2.32 Million USD | 0.0% |
2024 Q2 | 2.56 Million USD | 0.0% |
2024 Q4 | 3.93 Million USD | 0.0% |
2023 Q4 | 49.81 Million USD | 0.02% |
2023 Q3 | 49.8 Million USD | 0.02% |
2023 Q2 | 49.79 Million USD | -0.0% |
2023 Q1 | 49.79 Million USD | 99.19% |
2023 FY | 49.81 Million USD | 99.27% |
2022 Q1 | 25 Million USD | 25.0% |
2022 FY | 25 Million USD | 25.0% |
2022 Q2 | 25 Million USD | 0.0% |
2022 Q4 | 25 Million USD | 0.0% |
2022 Q3 | 25 Million USD | 0.0% |
2021 Q1 | 40 Million USD | 0.0% |
2021 Q4 | 20 Million USD | -33.33% |
2021 Q2 | 40 Million USD | 0.0% |
2021 Q3 | 30 Million USD | -25.0% |
2021 FY | 20 Million USD | -50.0% |
2020 FY | 40 Million USD | -67.85% |
2020 Q2 | 3.19 Million USD | -8.54% |
2020 Q3 | 14.34 Million USD | 349.42% |
2020 Q4 | 40 Million USD | 178.92% |
2020 Q1 | 3.48 Million USD | -97.2% |
2019 Q2 | 139.26 Million USD | 62.99% |
2019 Q1 | 85.44 Million USD | -1.36% |
2019 FY | 124.4 Million USD | 43.62% |
2019 Q3 | 126.83 Million USD | -8.92% |
2019 Q4 | 124.4 Million USD | -1.92% |
2018 FY | 86.62 Million USD | -5.15% |
2018 Q1 | 90.14 Million USD | -1.28% |
2018 Q2 | 88.97 Million USD | -1.3% |
2018 Q3 | 87.79 Million USD | -1.32% |
2018 Q4 | 86.62 Million USD | -1.34% |
2017 Q3 | 92.51 Million USD | -16.02% |
2017 FY | 91.32 Million USD | -13.16% |
2017 Q4 | 91.32 Million USD | -1.3% |
2017 Q2 | 110.16 Million USD | 9.45% |
2017 Q1 | 100.65 Million USD | -4.29% |
2016 Q3 | 113.91 Million USD | -7.13% |
2016 Q4 | 105.16 Million USD | -7.68% |
2016 Q1 | 126.41 Million USD | -1.94% |
2016 FY | 105.16 Million USD | -18.42% |
2016 Q2 | 122.66 Million USD | -2.97% |
2015 FY | 128.91 Million USD | -6.36% |
2015 Q4 | 128.91 Million USD | -8.84% |
2015 Q3 | 141.41 Million USD | -5.04% |
2015 Q2 | 148.91 Million USD | 9.16% |
2015 Q1 | 136.41 Million USD | -0.91% |
2014 Q2 | 135.16 Million USD | 4.47% |
2014 FY | 137.66 Million USD | 1.97% |
2014 Q3 | 133.91 Million USD | -0.92% |
2014 Q4 | 137.66 Million USD | 2.8% |
2014 Q1 | 129.37 Million USD | -4.17% |
2013 FY | 135 Million USD | -5.26% |
2013 Q4 | 135 Million USD | -1.37% |
2013 Q2 | 138.75 Million USD | -2.36% |
2013 Q1 | 142.1 Million USD | -0.28% |
2013 Q3 | 136.87 Million USD | -1.35% |
2012 Q1 | 6.2 Million USD | -1.2% |
2012 Q2 | 6.12 Million USD | -1.21% |
2012 Q3 | 6.05 Million USD | -1.22% |
2012 Q4 | 142.5 Million USD | 2255.37% |
2012 FY | 142.5 Million USD | 2170.92% |
2011 Q3 | 6.34 Million USD | -1.01% |
2011 Q1 | 6.48 Million USD | -0.99% |
2011 FY | 6.27 Million USD | -4.2% |
2011 Q4 | 6.27 Million USD | -1.1% |
2011 Q2 | 6.41 Million USD | -1.16% |
2010 Q3 | 6.61 Million USD | -0.97% |
2010 Q4 | 6.55 Million USD | -0.98% |
2010 FY | 6.55 Million USD | -3.82% |
2010 Q2 | 6.68 Million USD | -0.96% |
2010 Q1 | 6.74 Million USD | -0.95% |
2009 Q3 | 6.81 Million USD | -1.73% |
2009 Q4 | 6.81 Million USD | 0.0% |
2009 FY | 6.81 Million USD | -3.75% |
2009 Q2 | 6.93 Million USD | -0.86% |
2009 Q1 | 6.99 Million USD | -1.2% |
2008 Q2 | 7.24 Million USD | -2.23% |
2008 Q4 | 7.07 Million USD | -1.19% |
2008 Q3 | 7.16 Million USD | -1.17% |
2008 FY | 7.07 Million USD | -58.66% |
2008 Q1 | 7.41 Million USD | -56.7% |
2007 Q1 | 2.71 Million USD | -1.63% |
2007 Q4 | 17.11 Million USD | -0.49% |
2007 Q3 | 17.2 Million USD | 545.4% |
2007 Q2 | 2.66 Million USD | -1.66% |
2007 FY | 17.11 Million USD | 521.23% |
2006 Q4 | 2.75 Million USD | -1.61% |
2006 Q2 | 2.84 Million USD | -1.56% |
2006 Q1 | 2.89 Million USD | -1.53% |
2006 FY | 2.75 Million USD | -6.13% |
2006 Q3 | 2.8 Million USD | -1.58% |
2005 Q3 | 2.98 Million USD | -1.32% |
2005 Q1 | 3.06 Million USD | -1.29% |
2005 Q2 | 3.02 Million USD | -1.31% |
2005 FY | 2.93 Million USD | -5.32% |
2005 Q4 | 2.93 Million USD | -1.51% |
2004 Q4 | 3.1 Million USD | -83.93% |
2004 Q3 | 19.28 Million USD | 0.0% |
2004 FY | 3.1 Million USD | -84.02% |
2003 FY | 19.4 Million USD | 27.95% |
2003 Q4 | 19.4 Million USD | 0.0% |
2002 FY | 15.16 Million USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 75.25 Million USD | 94.766% |
AtriCure, Inc. | 60.59 Million USD | 93.499% |
Avinger, Inc. | - USD | -Infinity% |
Azenta, Inc. | 60.43 Million USD | 93.482% |
BioLife Solutions, Inc. | 18.31 Million USD | 78.488% |
The Cooper Companies, Inc. | 2.52 Billion USD | 99.844% |
Daxor Corporation | 755.65 Thousand USD | -421.267% |
Ekso Bionics Holdings, Inc. | 4.83 Million USD | 18.481% |
Femasys Inc. | 4.25 Million USD | 7.496% |
GlucoTrack, Inc. | 196 Thousand USD | -1909.694% |
Harvard Bioscience, Inc. | 30.7 Million USD | 87.171% |
Hologic, Inc. | 2.49 Billion USD | 99.842% |
ICU Medical, Inc. | 1.57 Billion USD | 99.75% |
Intuitive Surgical, Inc. | -82.1 Million USD | 104.798% |
KORU Medical Systems, Inc. | 3.65 Million USD | -7.831% |
LeMaitre Vascular, Inc. | 16.62 Million USD | 76.305% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 871.7 Million USD | 99.548% |
Microbot Medical Inc. | 40 Thousand USD | -9747.5% |
Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -85679.617% |
Merit Medical Systems, Inc. | 823.01 Million USD | 99.521% |
Nephros, Inc. | 1.39 Million USD | -183.381% |
NovoCure Limited | 596.24 Million USD | 99.339% |
NEXGEL, Inc. | 513 Thousand USD | -667.836% |
NEXGEL, Inc. | 513 Thousand USD | -667.836% |
Singular Genomics Systems, Inc. | 67.52 Million USD | 94.167% |
OraSure Technologies, Inc. | 11.38 Million USD | 65.411% |
Pro-Dex, Inc. | 7.53 Million USD | 47.731% |
Pulse Biosciences, Inc. | 8.08 Million USD | 51.286% |
Predictive Oncology Inc. | 2.18 Million USD | -79.947% |
Precision Optics Corporation, Inc. | 1.93 Million USD | -103.254% |
QuidelOrtho Corporation | 2.27 Billion USD | 99.827% |
Repligen Corporation | 510.14 Million USD | 99.228% |
Sanara MedTech Inc. | 9.11 Million USD | 56.777% |
STAAR Surgical Company | 31.46 Million USD | 87.482% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 295 Thousand USD | -1235.254% |
DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.781% |
Jin Medical International Ltd. | - USD | -Infinity% |